It was non-compliance with good manufacturing practices (GMP) at Bharat Biotech's flagship vaccine manufacturing facility at Hyderabad's Genome Valley that led to the World Health Organisation (WHO) suspending Covaxin supply for UN procurement.
from Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/DzAF9Mx
Home »
Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com
» Bharat Bio's Telangana unit failed GMP test, led to Covaxin suspension: WHO
https://ift.tt/FdrT5zB
No comments:
Post a Comment